Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer

被引:0
作者
A Lugli
G Iezzi
I Hostettler
M G Muraro
V Mele
L Tornillo
V Carafa
G Spagnoli
L Terracciano
I Zlobec
机构
[1] Institute of Pathology,
[2] University of Basel,undefined
[3] Institute for Surgical Research and Hospital Management,undefined
[4] University of Basel,undefined
来源
British Journal of Cancer | 2010年 / 103卷
关键词
colorectal cancer; cancer stem cell; CD44; CD166; CD133; EpCAM;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:382 / 390
页数:8
相关论文
共 282 条
  • [31] Nicosia SV(2001)Stem cells, cancer, and cancer stem cells Nature 414 105-139
  • [32] Cooper HS(2007)Identification and expansion of human colon-cancer-initiating cells Nature 445 111-2120
  • [33] Dalerba P(2007)Frequency and prognostic significance of occult tumor cells in lymph nodes in patients with adenocarcinoma of the papilla of Vater HPB (Oxford) 9 135-395
  • [34] Cho RW(2008)CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors J Clin Invest 118 2111-768
  • [35] Clarke MF(2007)Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule Am J Pathol 171 386-1611
  • [36] Dalerba P(2008)Cancer stem cells in solid tumours: accumulating evidence and unresolved questions Nat Rev Cancer 8 755-1164
  • [37] Dylla SJ(1998)Decreased expression of CD44 splicing variants in advanced colorectal carcinomas Eur J Cancer 34 1607-87
  • [38] Park IK(2004)ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival J Clin Pathol 57 1160-1537
  • [39] Liu R(1998)CD44 splice variants as prognostic markers in colorectal cancer Scand J Gastroenterol 33 82-823
  • [40] Wang X(1997)General mechanisms of metastasis Cancer 80 1529-575